
Purpose of Capital Alliance
EPSHD has developed its outsourcing business in pharmaceutical and medical device development with CRO1, SMO2, and CSO*3 at its core.
We are conducting a management buyout (MBO) in 2021 and expanding our activities into new areas with the aim of becoming a solution company for the entire healthcare industry that transcends conventional boundaries.
Logos Science was founded in 2022 by Ig nobel laureate Hideki Tanemura with the aim of providing new solution services in the field of mental health. Based on joint research with the Institute for Applied Brain Science, Waseda University Integrated Research Organization, Logos Science is currently engaged in the development of a mental health self-care application "Dr. AppliⓇ" *4 that helps solve problems and troubles associated with stress-related disorders. The company is involved in the development of a mental health self-care application, "Dr. AppliⓇ" *4, based on joint research with the Institute for Applied Brain Science, Waseda University.
In a clinical study (feasibility study) to verify the feasibility of practical application, "Dr.appliⓇ" was evaluated for its usability and safety, and achieved favorable results, including significant improvements in outcome measures.
EPSHD and Logos Science will not only form a capital alliance, but will also work as strategic partners to solve social issues by combining EPSHD's knowledge in the healthcare field cultivated through its pharmaceutical and medical device development business with the psychotherapy program based on Logos Science's "Dr. AppsⓇ ". AppⓇ , and by combining EPSHD's knowledge in the healthcare field gained through its pharmaceutical and medical device development business with the psychotherapy program based on Logos Science's Dr. AppⓇ , EPSHD will develop self-care applications in the mental health field, build evidence for these applications, and promote marketing activities to solve social issues.
Details
In recent years, the number of patients with mental disorders has been on the rise, reaching approximately 4.2 million according to a patient survey conducted by the Ministry of Health, Labor and Welfare in 2017. Of these, depression, a stress-related disorder, accounts for the largest number at 1.27 million. In particular, suicides among young people, declining labor productivity due to presenteeism in companies, and the prevalence of vague anxiety in the recent Corona disaster have become social problems.
Early detection and prevention of stress-related illnesses has been emphasized by the Ministry of Health, Labor and Welfare (MHLW) through stress checks and other mental health and overwork measures in the workplace, but awareness of specific preventive measures and self-care methods is not widespread.
The "Dr. AppliⓇ" is currently being developed by Logos Science in collaboration with the Institute for Applied Brain Science, Waseda University, and is an application program that replicates cognitive behavioral therapy and other psychotherapies, including acceptance and commitment therapy (ACT), which are conducted by professionals in clinical psychology settings. The feasibility of its practical application was confirmed in a clinical feasibility study.
Related Press Releases
Developed and completed a clinical study (feasibility study) of "Dr. AppliⓇ ," an application that supports the resolution of problems and distress associated with stress-related illnesses
https://prtimes.jp/main/html/rd/p/000000001.000105323.html
By developing a mental health self-care application that combines such a psychotherapy program based on Logos Science's "Dr. AppⓇ " with EPSHD's knowledge in the healthcare domain cultivated through its pharmaceutical and medical device development business, early detection of mental health problems and high quality self-care methods will be provided to companies and individuals. By providing companies and individuals with a high quality self-care method, it is expected to lead to the prevention of mental health problems.
EPSHD and Logos Science will work together to bring a mental health self-care application especially for companies and workers to practical use in 2023.
The EPS Group, which is taking off to a new stage as a solution provider 30 years after its establishment, and Logos Science, which is taking on the challenge of research and development to provide new solution services in the mental health field, will synergize their efforts to create value that leads to social innovation. We aim to create value that leads to social innovation.
Details of Capital Alliance
EPSHD will acquire [90,000] shares of common stock issued by Logos Science for the purpose of promoting joint business in the area of mental health.
Date of investment contract
Date of investment agreement March 3, 2023
About EPS Holdings
Since its establishment in 1991 as a pioneer CRO, we have been a healthcare solutions provider offering new value to pharmaceutical and medical device companies, hospitals/clinics, and academia through our solutions in development, drug development, marketing, sales, consultation, etc., as well as our initiatives in Big Data & AI, regenerative medicine, etc. In 2021, we launched our drug discovery business and began providing clinical development support for seeds from academia and domestic and international bio-ventures, as well as marketing support services in Japan and overseas.
About Logos Science
Founded in 2022, we are engaged in the app/system development business for stress-related diseases and mental health care. We aim to realize wellbeing through the science of language, and contribute to the realization of a society without suffering by helping to solve social issues through our app/system development business for stress-related diseases and mental health care.
*1: CRO (Contract Research Organization)
*2: Site Management Organization (SMO)
*3: CSO (Contract Sales Organization)
*4: "Dr. AppliⓇ" is a registered trademark of Logos Science Inc.
| name of company | Logos Science Corporation |
| Establishment | Feb. 2022 |
| Location | Shin Toranomon Jitsugyo Kaikan 5F, 1-1-21 Toranomon, Minato-ku, Tokyo |
| representative | Hideki Tanemura |
| uniform resouce locator | https://logossjp.com/ |









